Advertisements

Stocking Stuffers

 

Akari Therapeutics Plc (AKTX) Stock Quote

Detailed Quote for Akari Therapeutics Plc (AKTX)
$ 4.10   0.04 (+0.99%) Volume: 537.72k 4:00 PM EDT Mar 22, 2019
After Hours:  $ 4.10 0.00 (0.00%) Volume: 1.09k 6:43 PM EDT Mar 22, 2019
Today 5d 1m 3m 1y more
Last Price
4.10
Change $
0.04
Change %
0.99%
Tick
  
Bid
3.67
Bid Size
300
Ask
4.50
Ask Size
1,200
Open
3.99
High
4.30
Low
3.85
Prev Close
4.06
Last Trade
03/22/19
Volume
537.72k
52 Wk Hi
9.1999998
52 Wk Low
1.55999994
Market Cap
64.81m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
15,806,934
EPS (TTM)
-2.31999993
PE Ratio
N/A
Exchange
NCM
News and Media for Akari Therapeutics Plc (AKTX)
Sector News | Topic News
News for Akari Therapeutics Plc (AKTX)
Tue, Mar 19, 2019
9:13 AM SDRL, SBGL and CRBP among premarket gainers - SeekingAlpha
Mon, Mar 18, 2019
2:30 PM These Tech Stocks Could Test March Highs - ACCESSWIRE IA
12:46 PM Healthcare names top midday movers - SeekingAlpha
9:25 AM RIOT, PXLW and ATOS among premarket gainers - SeekingAlpha
Fri, Mar 15, 2019
12:54 PM Midday Gainers / Losers - SeekingAlpha
9:19 AM KIRK and FRSX among premarket losers - SeekingAlpha
Thu, Mar 14, 2019
12:44 PM CLDR, TLRD, MDB and WAGE among midday movers - SeekingAlpha
9:27 AM PLUG, TNXP among premarket gainers - SeekingAlpha
8:15 AM Advancing Clinical Trials For Leukemia Patients Is Helping Improve Survival Rate - Financial News Media
Wed, Mar 13, 2019
2:35 PM These 4 Tech Stocks Are On The Rise On Wednesday (3/13/19) - ACCESSWIRE IA
12:47 PM Midday Gainers / Losers - SeekingAlpha
9:37 AM Akari up 15% on FDA nod on trial design for Coversin - SeekingAlpha
9:18 AM CLNE, ACB and CARA among premarket gainers - SeekingAlpha
8:30 AM Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics's Coversin in Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) - GlobeNewswire
Fri, Nov 30, 2018
4:40 PM Akari announces new Coversin data, key readouts expected next quarter - SeekingAlpha
4:05 PM Akari Therapeutics Announces New Data Highlighting Differentiation of Drug Candidate Coversin - GlobeNewswire
More News for AKTX >>
Filings for Akari Therapeutics Plc (AKTX)
Wed, Mar 13, 2019
3:00 AM Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act - Form 6-K
Mon, Mar 04, 2019
3:00 AM This filing is a pre-effective amendment to an F-1 filing - Form F-1/A
Fri, Mar 01, 2019
3:00 AM This filing is a pre-effective amendment to an F-1 filing - Form F-1/A
Thu, Feb 14, 2019
3:00 AM This filing is a pre-effective amendment to an F-1 filing - Form F-1/A
More Filings for AKTX >>

Tags for Akari Therapeutics Plc

Research stocks or mutual funds related to Akari Therapeutics Plc by keywords or tags. Find companies that have a similar focus to AKTX. The keywords below have been associated to AKTX by either user submission or electronic means.